29FA Intenzo, Charles M. - Thomas Jefferson University - Thomas Jefferson University
cmi101

Charles Intenzo, MD

Contact Dr. Intenzo

132 South 10th Street
Suite 861, Main Building
Philadelphia, PA 19107

(215) 955-7871
(215) 923-0268 fax

Most Recent Peer-reviewed Publications

  1. VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  2. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  3. Provider Distribution Changes in Dual-Energy X-Ray Absorptiometry in the Medicare Population Over the Past Decade
  4. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
  5. Clinical comparison of99mTc exametazime and123I ioflupane SPECT in patients with chronic mild traumatic brain injury
  6. Effectiveness of PET/CT in the preoperative evaluation of neck disease
  7. VPAC1 receptors for imaging breast cancer: A feasibility study
  8. Altered drainage patterns in patients with melanoma and previous axillary dissection
  9. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma
  10. Recent reimbursement changes and their effect on hospital and private office use of myocardial perfusion imaging
  11. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
  12. SNM practice guideline for parathyroid scintigraphy 4.0
  13. Positron Emission Tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma
  14. Imaging of the thyroid in benign and malignant disease
  15. Subclinical hyperthyroidism: Current concepts and scintigraphic imaging
  16. A phase i trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: First report of a completed study
  17. FDG-PET staging and importance of lymph node SUV in head and neck cancer
  18. Lymphoscintigraphy in cutaneous melanoma: An updated total body atlas of sentinel node mapping
  19. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer
  20. Recent Payment and Utilization Trends in Radionuclide Myocardial Perfusion Imaging: Comparison Between Self-Referral and Referral to Radiologists
0